| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Endonovo Therapeutics, Inc. (ENDV) has 0 insiders with recent SEC Form 4 filings, including 141 buys and 0 sells. ENDV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 10, 2019 | Collier Alan Brian | CEO | Buy | 160,774 | $0.01 | $1,903.68 | - | |
| May 6, 2019 | Collier Alan Brian | CEO | Buy | 255,000 | $0.01 | $2,858.93 | - | |
| May 2, 2019 | Collier Alan Brian | CEO | Buy | 179,000 | $0.01 | $1,974.00 | - | |
| Apr 29, 2019 | Collier Alan Brian | CEO | Buy | 40,000 | $0.01 | $596.10 | - | |
| Apr 25, 2019 | Collier Alan Brian | CEO | Buy | 57,000 | $0.01 | $673.20 | - | |
| Apr 24, 2019 | Collier Alan Brian | CEO | Buy | 48,000 | $0.01 | $675.80 | - | |
| Apr 12, 2019 | Collier Alan Brian | CEO | Buy | 13,500 | $0.02 | $230.20 | - | |
| Apr 3, 2019 | Collier Alan Brian | CEO | Buy | 36,000 | $0.02 | $632.20 | - | |
| Mar 29, 2019 | Mann Michael Scott | President | Buy | 5,000 | $0.02 | $84.50 | - | |
| Mar 27, 2019 | Collier Alan Brian | CEO | Buy | 54,000 | $0.02 | $982.40 | - |